Learn more about NxGEN’s technology to reduce the body’s immune reaction toward your AAV vectors, leading to safe, effective, and durable therapeutic gene expression in the Cell and Gene Therapy Supplement of Genetic Engineering & Biotechnology News (GEN) Magazine below.
April 21st, 2023 - Partner with NxGEN Vector Solutions to apply NxGEN Technology to your AAV vectors and eliminate the immune response that limits transgene durability.
